Company Overview

Development Stage

About the Company

汇宇制药成立于2010年,是一家研发驱动的综合制药企业,主要从事抗肿瘤和注射剂药物的研发、生产和销售。公司总部和生产基地位于内江市*经济技术开发区,研发中心坐落于成都市天府国际生物城,并且在美国、英国和爱尔兰等地设有子公司.愿景 成为一家受人尊敬的国际化制药企业 使命 为全球患者提供疗效确切、质量精湛、价格合理的药品,让癌症成为一种可以控制的疾病 核心价值观 关爱生命,追求卓越,简单诚信

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

Master's Degree Job Demand Analysis

(More)
How fast is master's hiring at 四川汇宇悦迎医药科技有限公司 growing? Master's recruitment over the years: 2026: 34 openings (up 119%), 2025: 9 openings (up 2050%).

R&D Strength (Technical Talent Demand)

(More)
How is the demand for technical talent at 四川汇宇悦迎医药科技有限公司? Based on an analysis of 's job postings over the past year, "医疗卫生/美容保健类" demand: 19.1%, "生物/制药/化工/环保类": 14.5%, "其他(研发和技术类)": 11.9%, "科研类": 11.9%, "计算机/网络/技术类": 7.7%, "电子/电器/通信技术类": 0.9%. For reference only.

— What Are the Salaries Like? (235 records)

Manage
salary range: 2K - 50K, 66.9% of roles pay ¥10-30K
Note: salary statistics are based on 235 salary records from the past year and depend on the job sample. For reference only.
How is the salary at 四川汇宇悦迎医药科技有限公司?66.9% of positions earn 10-30K, Fresh graduate salary: ¥2.3K。Chengdu salary ranking top 50,经营管理类 average salary ¥23.2K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

Salaries for hot jobs of

(More)
Are salaries high at 四川汇宇悦迎医药科技有限公司? We provide: 研究员,招商,dm,临床,项目经理,市场,质量,销售,业务经理,大区总监,医学经理,省区经理,车间,科学家,高级经理,qc,产品经理,地区经理,报关,采购. Click to view detailed salary analysis by job.

honors, qualifications & industry associations

Tags are labelled based on keyword text matching analysis and may be related to the company. For reference only.

Related Industry Tags

Job Category

  • 经营管理类
    35.1% of total 35.1%
  • 销售类
    31.4% of total 31.4%
  • 医疗卫生/美容保健类
    19.2% of total 19.2%
  • 生物/制药/化工/环保类
    15.5% of total 15.5%

Education

  • 本科
    54.8% of total 54.8%
  • 大专
    20.9% of total 20.9%
  • 硕士
    15.5% of total 15.5%
  • 博士
    5% of total 5%

Experience

  • 3-5年
    38.5% of total 38.5%
  • 5-10年
    30.1% of total 30.1%
  • 1-3年
    27.2% of total 27.2%
  • 不限
    2.9% of total 2.9%
View Detailed Analysis

What does 四川汇宇悦迎医药科技有限公司 require? Who is 四川汇宇悦迎医药科技有限公司 hiring? recruitment: 经营管理类占比最多占35.1%,其次是销售类占31.4%. What education can get in at ? 本科占比最多占54.8%,其次是大专占20.9%. High education required at ? 硕士占15.5%,博士占5%. Work experience required at ? 3-5年占比最多占38.5%,其次是5-10年占30.1%. Where are the job locations at ? 成都占比最多占46.4%,其次是内江占22.2%. Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 2,800万(元)
Legal Representative: 丁兆
Date Established:
Credit Code: 91510100MA62KLL26M
Registered Address: 成都天府国际生物城(双流区岐黄二路1533号3号楼4楼415室-418室)

People who follow this company also follow

Competitors (Similar Companies)

“Dedicated to the R&D, production, and sales of high-end anti-tumor dru”
“A pharmaceutical group committed to the research, development, product”
“Let everyone have trust and expectation in Baili because of health!”
“To develop high-quality biologics that are accessible and affordable f”
医药 生物医药 单克隆抗体药物 高通量筛选
医药 生物制品 化学制药 药物研发
“Adhering to the pursuit of high quality”
“成为绿色化学领域的世界品牌企业”
“创新药物研发商”
V
“Health for all, vitality for life!”
“Primarily engaged in the research and development, production, and sal”
医药 医药中间体 原料药 化学制药
医药 药学研究 仿制药 原料
原料 生物科技/生物工程 生命科学 生物制品
“创新药物研发及产业化服务商”

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates